NCT03453307View on ClinicalTrials.gov

Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients

UnknownOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

July 30, 2020

Study Completion Date

July 30, 2021

Conditions

NSCLC

Trial Locations (1)

050051

RECRUITING

People's Hospital of Hebei Province, Shijiazhuang

Sponsors

Lead Sponsor

K2 Oncology, Inc.

All Listed Sponsors

lead

K2 Oncology, Inc.

INDUSTRY

NCT03453307 - Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients | Biotech Hunter | Biotech Hunter